The global Anticoagulant Market commonly referred to as blood thinners, are life-saving pharmacological agents designed to prevent and treat blood clots in conditions such as atrial fibrillation, deep vein thrombosis (DVT), and pulmonary embolism (PE). In 2025, the market has reached a critical maturity phase where Direct Oral Anticoagulants (DOACs) are not only the gold standard but ... https://livepositively.com/unlocking-value-pricing-regulatory-landscape-and-future-forecast-for-the-ocular-bromfenac-market-2025-2032/